Reflect Scientific, Inc.: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Nov 19, 2019 and accepted by EDGAR at Nov 18, 2019, 18:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $366.4k | us-gaap:Revenues |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $977.3k | us-gaap:Revenues |
| Cost of revenue | 3 months2019-07-01 to 2019-09-30 | $101.4k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-30 | $300.9k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-07-01 to 2019-09-30 | $265.1k | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-30 | $676.4k | us-gaap:GrossProfit |
| Research and development | 3 months2019-07-01 to 2019-09-30 | $75.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-30 | $105.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-07-01 to 2019-09-30 | $3.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-30 | −$21.7k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-07-01 to 2019-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $1.5k | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-30 | −$22.2k | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | $237.5k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | At period end2019-09-30 | $457.1k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $684.0k | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $813.0k | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $304.7k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-30 | $317.5k | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-09-30 | $495.5k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001548123-19-000223. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.